What Researchers Did
The researchers randomly assigned head and neck cancer patients to receive radiotherapy either while breathing oxygen in a hyperbaric chamber or while breathing air.
What They Found
In a prospective randomized controlled trial of radiotherapy for head and neck cancer, hyperbaric oxygen was linked to significantly better local tumour control than air, but survival did not differ between the two groups. Both groups got identical radiotherapy: 3500 rads in 10 fractions over 3 weeks. The better local control was seen particularly in smaller lesions. The air group had a significantly greater need for salvage surgery. Radiation effects on normal tissue appeared somewhat greater in the oxygen group, especially on laryngeal cartilage.
What This Means for Canadian Patients
For people with head and neck cancer, this trial found better local tumour control when radiotherapy was given in hyperbaric oxygen, but no difference in survival. It also reported somewhat greater radiation effects on normal tissue in the oxygen group, especially laryngeal cartilage. Anyone considering this approach should talk with their cancer care team about these benefits and risks.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The abstract does not report the number of patients, the oxygen pressure used, or exact statistics, and the radiotherapy schedule it describes (3500 rads in 10 fractions) comes from a 1977 trial, so it may differ from current practice.